학술논문
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Document Type
Article
Author
Bagley, S.J.; Desai, A.S.; Markowitz, K.; Delman, D.; Beatty, G.L.; Hexner, E.; Binder, Z.A.; Maloney, E.; Brem, S.; Logun, M.; O’Rourke, D.M.; Marshall, A.; Nasrallah, M.P.; Tang, O.Y.; Bhattacharyya, M.; Lamrani, L.; Alanio, C.; Bonté, P.-E.; Goudot, C.; Richer, W.; Piaggio, E.; Amigorena, S.; Wherry, E.J.; Marinari, E.; Migliorini, D.; Lustig, R.A.; Kurtz, G.; Alonso-Basanta, M.; Waterfall, J.J.; Kothari, S.; Guyonnet, L.; Guerin, C.L.; Mohan, S.; Hwang, W.-T.; Brogdon, J.L.
Source
In: Nature Cancer . (Nature Cancer, March 2024, 5(3):517-531)
Subject
Language
English
ISSN
26621347